HEADER TRANSFERASE 04-FEB-23 8I8G TITLE CRYSTAL STRUCTURE OF CPH001-D189N IN COMPLEX WITH CMN IIA AND ATP COMPND MOL_ID: 1; COMPND 2 MOLECULE: VIOMYCIN KINASE; COMPND 3 CHAIN: B, A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: KBE-DPP-UAL-MYN-DPP-SER; COMPND 7 CHAIN: D; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: CMN IIA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOSPORANGIUM ROSEUM; SOURCE 3 ORGANISM_TAXID: 2001; SOURCE 4 GENE: SROS_4606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: SACCHAROTHRIX MUTABILIS SUBSP. CAPREOLUS; SOURCE 9 ORGANISM_TAXID: 66854; SOURCE 10 EXPRESSION_SYSTEM: SACCHAROTHRIX MUTABILIS SUBSP. CAPREOLUS; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 66854 KEYWDS PHOSPHOTRANSFERASE, CAPREOMYCIN, CPH, RESISTANCE, TRANSFERASE, ATP EXPDTA X-RAY DIFFRACTION AUTHOR C.Y.CHANG,S.I.TOH,J.ELAINE K,P.Y.HSIAO REVDAT 1 10-JAN-24 8I8G 0 JRNL AUTH S.I.TOH,J.ELAINE KEISHA,Y.L.WANG,Y.C.PAN,Y.H.JHU,P.Y.HSIAO, JRNL AUTH 2 W.T.LIAO,P.Y.CHEN,T.M.KO,C.Y.CHANG JRNL TITL DISCOVERY AND CHARACTERIZATION OF GENES CONFERRING NATURAL JRNL TITL 2 RESISTANCE TO THE ANTITUBERCULOSIS ANTIBIOTIC CAPREOMYCIN. JRNL REF COMMUN BIOL V. 6 1282 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 38114770 JRNL DOI 10.1038/S42003-023-05681-6 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 8.0.004 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 11643 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.500 REMARK 3 FREE R VALUE TEST SET COUNT : 946 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4267 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.41000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.524 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8I8G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1300035154. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL15A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13117 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.14500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.49900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE TRIHYDRATE, REMARK 280 POLYETHYLENE GLYCOL 4,000, GLYCEROL, PH 4.6, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.14400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.97550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.53700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.97550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.14400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.53700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE CAPREOMYCIN IA IS CYCLIC PEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CAPREOMYCIN IA REMARK 400 CHAIN: D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 MET A 1 REMARK 465 GLU A 82 REMARK 465 GLY A 83 REMARK 465 ALA A 84 REMARK 465 VAL A 85 REMARK 465 GLU A 86 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 67 75.39 -106.76 REMARK 500 ALA B 140 73.94 -151.36 REMARK 500 ASN B 189 56.87 -157.69 REMARK 500 ASP B 211 76.93 57.35 REMARK 500 HIS A 27 91.95 -69.37 REMARK 500 ALA A 140 74.80 -153.85 REMARK 500 THR A 182 55.59 -140.91 REMARK 500 ASN A 189 59.05 -151.52 REMARK 500 LEU A 206 109.02 -59.10 REMARK 500 ASP A 211 77.34 74.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 311 DISTANCE = 7.02 ANGSTROMS DBREF 8I8G B 1 286 UNP D2B3F1 D2B3F1_STRRD 1 286 DBREF 8I8G A 1 286 UNP D2B3F1 D2B3F1_STRRD 1 286 DBREF 8I8G D 1 6 PDB 8I8G 8I8G 1 6 SEQADV 8I8G ASN B 189 UNP D2B3F1 ASP 189 ENGINEERED MUTATION SEQADV 8I8G ASN A 189 UNP D2B3F1 ASP 189 ENGINEERED MUTATION SEQRES 1 B 286 MET GLY ILE LEU GLN ALA ASN ARG VAL LEU LEU SER ARG SEQRES 2 B 286 LEU LEU PRO GLY VAL GLU PRO GLU GLY LEU THR VAL ARG SEQRES 3 B 286 HIS GLY GLN PHE HIS GLN VAL VAL ILE ALA SER ASP ARG SEQRES 4 B 286 VAL VAL CYS LEU PRO ARG THR ALA ALA ALA ALA ALA ARG SEQRES 5 B 286 LEU PRO ARG ARG ALA ALA VAL MET ARG VAL LEU ALA GLY SEQRES 6 B 286 LEU ASP LEU GLY CYS ARG THR PRO ARG PRO LEU CYS GLU SEQRES 7 B 286 GLY SER ALA GLU GLY ALA VAL GLU LEU PRO PHE LEU VAL SEQRES 8 B 286 LEU SER ARG VAL PRO GLY ALA PRO LEU GLU ALA ASP ALA SEQRES 9 B 286 LEU GLU ASP SER LYS VAL ALA GLU VAL VAL ALA ALA GLN SEQRES 10 B 286 TYR VAL THR LEU LEU SER GLY LEU ALA SER ALA GLY ALA SEQRES 11 B 286 ASP GLU LYS VAL ARG ALA ALA LEU PRO ALA PRO GLN GLY SEQRES 12 B 286 ARG TRP ARG GLN PHE ALA ALA ASP VAL ARG ALA GLU LEU SEQRES 13 B 286 PHE PRO LEU MET SER ASP GLY GLY CYS ARG GLN ALA GLU SEQRES 14 B 286 ARG GLU LEU ALA ALA LEU ASP SER LEU PRO ASP ILE THR SEQRES 15 B 286 GLU ALA VAL VAL HIS GLY ASN LEU GLY ALA GLU ASN VAL SEQRES 16 B 286 LEU TRP VAL ARG ASP ASP GLY LEU PRO ARG LEU SER GLY SEQRES 17 B 286 VAL ILE ASP TRP ASP GLU VAL SER ILE GLY ASP PRO ALA SEQRES 18 B 286 GLU ASP LEU ALA ALA ILE GLY ALA GLY TYR GLY LYS ASP SEQRES 19 B 286 PHE LEU ASP GLN VAL LEU THR LEU GLY GLY TRP SER ASP SEQRES 20 B 286 ARG ARG MET ALA THR ARG ILE ALA THR ILE ARG ALA THR SEQRES 21 B 286 PHE ALA LEU GLN GLN ALA LEU SER ALA CYS ARG ASP GLY SEQRES 22 B 286 ASP GLU GLU GLU LEU ALA ASP GLY LEU THR GLY TYR ARG SEQRES 1 A 286 MET GLY ILE LEU GLN ALA ASN ARG VAL LEU LEU SER ARG SEQRES 2 A 286 LEU LEU PRO GLY VAL GLU PRO GLU GLY LEU THR VAL ARG SEQRES 3 A 286 HIS GLY GLN PHE HIS GLN VAL VAL ILE ALA SER ASP ARG SEQRES 4 A 286 VAL VAL CYS LEU PRO ARG THR ALA ALA ALA ALA ALA ARG SEQRES 5 A 286 LEU PRO ARG ARG ALA ALA VAL MET ARG VAL LEU ALA GLY SEQRES 6 A 286 LEU ASP LEU GLY CYS ARG THR PRO ARG PRO LEU CYS GLU SEQRES 7 A 286 GLY SER ALA GLU GLY ALA VAL GLU LEU PRO PHE LEU VAL SEQRES 8 A 286 LEU SER ARG VAL PRO GLY ALA PRO LEU GLU ALA ASP ALA SEQRES 9 A 286 LEU GLU ASP SER LYS VAL ALA GLU VAL VAL ALA ALA GLN SEQRES 10 A 286 TYR VAL THR LEU LEU SER GLY LEU ALA SER ALA GLY ALA SEQRES 11 A 286 ASP GLU LYS VAL ARG ALA ALA LEU PRO ALA PRO GLN GLY SEQRES 12 A 286 ARG TRP ARG GLN PHE ALA ALA ASP VAL ARG ALA GLU LEU SEQRES 13 A 286 PHE PRO LEU MET SER ASP GLY GLY CYS ARG GLN ALA GLU SEQRES 14 A 286 ARG GLU LEU ALA ALA LEU ASP SER LEU PRO ASP ILE THR SEQRES 15 A 286 GLU ALA VAL VAL HIS GLY ASN LEU GLY ALA GLU ASN VAL SEQRES 16 A 286 LEU TRP VAL ARG ASP ASP GLY LEU PRO ARG LEU SER GLY SEQRES 17 A 286 VAL ILE ASP TRP ASP GLU VAL SER ILE GLY ASP PRO ALA SEQRES 18 A 286 GLU ASP LEU ALA ALA ILE GLY ALA GLY TYR GLY LYS ASP SEQRES 19 A 286 PHE LEU ASP GLN VAL LEU THR LEU GLY GLY TRP SER ASP SEQRES 20 A 286 ARG ARG MET ALA THR ARG ILE ALA THR ILE ARG ALA THR SEQRES 21 A 286 PHE ALA LEU GLN GLN ALA LEU SER ALA CYS ARG ASP GLY SEQRES 22 A 286 ASP GLU GLU GLU LEU ALA ASP GLY LEU THR GLY TYR ARG SEQRES 1 D 6 KBE DPP UAL MYN DPP SER HET KBE D 1 9 HET DPP D 2 6 HET UAL D 3 9 HET MYN D 4 11 HET DPP D 5 6 HET ATP A 401 31 HETNAM KBE BETA-LYSINE HETNAM DPP DIAMINOPROPANOIC ACID HETNAM UAL (2Z)-2-AMINO-3-(CARBAMOYLAMINO)PROP-2-ENOIC ACID HETNAM MYN (2S)-AMINO[(4R)-2-AMINO-1,4,5,6-TETRAHYDROPYRIMIDIN-4- HETNAM 2 MYN YL]ETHANOIC ACID HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETSYN KBE (3S)-3,6-DIAMINOHEXANOIC ACID FORMUL 3 KBE C6 H14 N2 O2 FORMUL 3 DPP 2(C3 H8 N2 O2) FORMUL 3 UAL C4 H7 N3 O3 FORMUL 3 MYN C6 H12 N4 O2 FORMUL 4 ATP C10 H16 N5 O13 P3 FORMUL 5 HOH *27(H2 O) HELIX 1 AA1 GLY B 2 ASN B 7 1 6 HELIX 2 AA2 ASN B 7 LEU B 15 1 9 HELIX 3 AA3 GLU B 19 LEU B 23 5 5 HELIX 4 AA4 THR B 46 ARG B 52 1 7 HELIX 5 AA5 ARG B 52 GLY B 65 1 14 HELIX 6 AA6 GLU B 78 GLU B 82 5 5 HELIX 7 AA7 ALA B 102 GLU B 106 5 5 HELIX 8 AA8 ASP B 107 GLY B 129 1 23 HELIX 9 AA9 ASP B 131 LEU B 138 1 8 HELIX 10 AB1 GLY B 143 LEU B 156 1 14 HELIX 11 AB2 PHE B 157 MET B 160 5 4 HELIX 12 AB3 SER B 161 ALA B 174 1 14 HELIX 13 AB4 GLY B 191 GLU B 193 5 3 HELIX 14 AB5 PRO B 220 GLY B 232 1 13 HELIX 15 AB6 GLY B 232 GLY B 244 1 13 HELIX 16 AB7 ASP B 247 GLY B 273 1 27 HELIX 17 AB8 ASP B 274 LEU B 282 1 9 HELIX 18 AB9 ILE A 3 ASN A 7 1 5 HELIX 19 AC1 ASN A 7 LEU A 15 1 9 HELIX 20 AC2 GLU A 19 LEU A 23 5 5 HELIX 21 AC3 THR A 46 GLY A 65 1 20 HELIX 22 AC4 ASP A 103 GLU A 106 5 4 HELIX 23 AC5 ASP A 107 ASP A 131 1 25 HELIX 24 AC6 ASP A 131 LEU A 138 1 8 HELIX 25 AC7 GLY A 143 LEU A 156 1 14 HELIX 26 AC8 PHE A 157 MET A 160 5 4 HELIX 27 AC9 SER A 161 LEU A 178 1 18 HELIX 28 AD1 GLY A 191 GLU A 193 5 3 HELIX 29 AD2 PRO A 220 GLY A 232 1 13 HELIX 30 AD3 GLY A 232 GLY A 244 1 13 HELIX 31 AD4 ASP A 247 ALA A 259 1 13 HELIX 32 AD5 THR A 260 ASP A 272 1 13 HELIX 33 AD6 ASP A 274 LEU A 282 1 9 HELIX 34 AD7 THR A 283 ARG A 286 5 4 SHEET 1 AA1 4 THR B 24 HIS B 27 0 SHEET 2 AA1 4 HIS B 31 ILE B 35 -1 O ILE B 35 N THR B 24 SHEET 3 AA1 4 ARG B 39 PRO B 44 -1 O VAL B 41 N VAL B 34 SHEET 4 AA1 4 LEU B 90 SER B 93 -1 O LEU B 92 N VAL B 40 SHEET 1 AA2 2 ALA B 184 VAL B 186 0 SHEET 2 AA2 2 SER B 216 GLY B 218 -1 O SER B 216 N VAL B 186 SHEET 1 AA3 2 VAL B 195 VAL B 198 0 SHEET 2 AA3 2 ARG B 205 VAL B 209 -1 O ARG B 205 N VAL B 198 SHEET 1 AA4 5 THR A 24 HIS A 27 0 SHEET 2 AA4 5 GLN A 32 ILE A 35 -1 O ILE A 35 N THR A 24 SHEET 3 AA4 5 ARG A 39 CYS A 42 -1 O VAL A 41 N VAL A 34 SHEET 4 AA4 5 PHE A 89 SER A 93 -1 O LEU A 90 N CYS A 42 SHEET 5 AA4 5 PRO A 75 GLY A 79 -1 N LEU A 76 O VAL A 91 SHEET 1 AA5 2 ALA A 184 VAL A 186 0 SHEET 2 AA5 2 SER A 216 GLY A 218 -1 O SER A 216 N VAL A 186 SHEET 1 AA6 2 VAL A 195 VAL A 198 0 SHEET 2 AA6 2 ARG A 205 VAL A 209 -1 O GLY A 208 N LEU A 196 LINK C KBE D 1 NG DPP D 2 1555 1555 1.46 LINK C DPP D 2 N UAL D 3 1555 1555 1.44 LINK N DPP D 2 C SER D 6 1555 1555 1.34 LINK C UAL D 3 N MYN D 4 1555 1555 1.47 LINK C MYN D 4 NG DPP D 5 1555 1555 1.44 LINK C DPP D 5 N SER D 6 1555 1555 1.34 CRYST1 82.288 87.074 87.951 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012152 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011484 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011370 0.00000